Discover 1,005 paid clinical trials in Minneapolis, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Minneapolis currently offers various active clinical trials with a focus on many chronic conditions, including asthma, arthritis, kidney disease, and hidradenitis suppurativa. The city’s leading healthcare institutions are recruiting participants to take part in paid research studies as healthy volunteers, as well as those looking for studies targeting specific health issues, providing access to innovative treatments and contributing to the development of new therapies.
Filter
2
Filter results
Results: 1,005
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
for
Coronary Artery Disease
Location: Minneapolis MN, Indianapolis IN, Cincinnati OH,
Sponsor: Kardion Inc
Sex: All
Age: 18 - 70+
Code: NCT06445608
Recruiting
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
for
Coronary Artery Disease
Location: Minneapolis MN, Cleveland OH, Charlottesville VA
Location: Minneapolis MN, Saint Cloud MN, Glenview IL, Chicago IL,
Sponsor: JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
Sex: All
Age: 18+
Code: NCT06455787
Recruiting
STRess Assessment of INterventional Cardiology Fellows and Attendings
for
Stress
Location: Minneapolis MN
Sponsor: Minneapolis Heart Institute Foundation
Sex: All
Age: 18+
Code: NCT07804927
Recruiting
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
for
Aortic Regurgitation, Aortic Valve Insufficiency,
Location: Minneapolis MN, Rochester MN, Chicago IL,
Sponsor: JenaValve Technology, Inc.
Sex: All
Age: 0+
Code: NCT06608823
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Minneapolis MN, Omaha NE, Milwaukee WI, Chicago IL,